- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunotherapy in Ovarian Cancer ; volume:70 ; number:1 ; day:9 ; month:8 ; year:2022 ; pages:1-8 ; date:12.2022
Archivum immunologiae et therapiae experimentalis ; 70, Heft 1 (9.8.2022), 1-8, 12.2022
- Creator
-
Siminiak, Natalia
Czepczyński, Rafał
Zaborowski, Mikołaj Piotr
Iżycki, Dariusz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00005-022-00655-8
- URN
-
urn:nbn:de:101:1-2022102700131952376195
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Siminiak, Natalia
- Czepczyński, Rafał
- Zaborowski, Mikołaj Piotr
- Iżycki, Dariusz
- SpringerLink (Online service)
Other Objects (12)
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer